ÂÜÀòÂÒÂ×

Edward brings more than 30 years of experience in the biotech industry to Gerostate Alpha, with expertise in growing a biotech company from inception to a publicly traded company. Edward is the former CEO of Sangamo Therapetuics (SGMO), where he helped pioneer the field of genome editing.

He has substantial experience in developing therapeutics, from the bench to the bedside, and in addition to his role as founder and CEO of Sangamo, he formerly held positions in Synergen, Eli Lily, and was Chairman of the Board at Alliance for Regenerative Medicine.